• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC).

作者信息

Hoffe S, Frakes J M, Aguilera T A, Czito B, Palta M, Brookes M, Schweizer C, Colbert L, Moningi S, Bhutani M S, Pant S, Tzeng C W, Tidwell R S, Thall P, Yuan Y, Moser E C, Holmlund J, Herman J, Taniguchi C M

机构信息

H. Lee Moffitt Cancer Center and Research Institute, Department of Radiation Oncology, Tampa, FL.

Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX.

出版信息

Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1399-1400. doi: 10.1016/j.ijrobp.2020.09.022. Epub 2020 Nov 18.

DOI:10.1016/j.ijrobp.2020.09.022
PMID:33427657
Abstract
摘要

相似文献

1
Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC).GC 4419（一种模拟歧化酶）联合高剂量立体定向体部放疗（SBRT）治疗局部晚期胰腺癌（PC）的随机、双盲、安慰剂对照多中心1-2期适应性试验
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1399-1400. doi: 10.1016/j.ijrobp.2020.09.022. Epub 2020 Nov 18.
2
Erratum to: Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC)  Int J Radiat Oncol Biol Phys 2020;108:1399-1400.《错配酶模拟物GC 4419联合高剂量立体定向体部放射治疗（SBRT）用于局部晚期胰腺癌（PC）的随机、双盲、安慰剂对照多中心1-2期适应性试验》勘误 国际放射肿瘤学、生物学、物理学杂志2020年；108:1399-1400 。
Int J Radiat Oncol Biol Phys. 2023 Jul 1;116(3):698. doi: 10.1016/j.ijrobp.2023.01.025.
3
Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial.立体定向体部放疗剂量递增联合帕博利珠单抗和曲美替尼与立体定向体部放疗剂量递增联合吉西他滨治疗手术切除后局部复发性胰腺癌对生存结果的影响：一项开放标签、随机、对照、2期试验的二次分析
EClinicalMedicine. 2022 Dec 1;55:101764. doi: 10.1016/j.eclinm.2022.101764. eCollection 2023 Jan.
4
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.AGITG 主计划：一项改良 FOLFIRINOX 单独或联合立体定向体部放疗治疗高危和局部进展期胰腺癌患者的随机 II 期研究。
BMC Cancer. 2021 Aug 19;21(1):936. doi: 10.1186/s12885-021-08666-y.
5
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).MR 引导自适应立体定向体部放疗（SBRT）治疗转移性胰腺导管腺癌（mPDAC）疼痛的初步研究：一项开放、随机、多中心、平行组临床试验（MASPAC）。
Radiat Oncol. 2022 Jan 25;17(1):18. doi: 10.1186/s13014-022-01988-6.
6
Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysis.常规分割放疗与立体定向体部放疗治疗局部晚期胰腺癌（CRiSP）：国际系统评价和荟萃分析。
Cancer. 2020 May 15;126(10):2120-2131. doi: 10.1002/cncr.32756. Epub 2020 Mar 3.
7
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.评估吉西他滨与立体定向体部放疗用于局部晚期不可切除胰腺腺癌患者的2期多机构试验。
Cancer. 2015 Apr 1;121(7):1128-37. doi: 10.1002/cncr.29161. Epub 2014 Dec 23.
8
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.磁共振引导自适应与 ITV 基础立体定向体部放疗治疗肝转移瘤（MAESTRO）：一项随机对照的 II 期临床试验。
Radiat Oncol. 2022 Mar 27;17(1):59. doi: 10.1186/s13014-022-02033-2.
9
Induction FOLFIRINOX followed by stereotactic body radiation therapy in locally advanced pancreatic cancer.局部晚期胰腺癌患者先行诱导性FOLFIRINOX方案治疗，随后接受立体定向体部放射治疗。
Front Oncol. 2022 Dec 14;12:1050070. doi: 10.3389/fonc.2022.1050070. eCollection 2022.
10
A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome.一项针对局部进展期胰腺癌（LAPC-1 试验）患者在接受 FOLFIRINOX 后行立体定向放疗的 II 期研究：长期结果。
Radiother Oncol. 2021 Feb;155:232-236. doi: 10.1016/j.radonc.2020.11.006. Epub 2020 Nov 17.

引用本文的文献

1
Superoxide Dismutase Mimetic Avasopasem Manganese Enhances Radiation Therapy Effectiveness in Soft Tissue Sarcomas and Accelerates Wound Healing.超氧化物歧化酶模拟物阿伐索帕森锰增强软组织肉瘤的放射治疗效果并加速伤口愈合。
Antioxidants (Basel). 2024 May 10;13(5):587. doi: 10.3390/antiox13050587.
2
Advances in Radiation Oncology for Pancreatic Cancer: An Updated Review.胰腺癌放射肿瘤学进展：最新综述
Cancers (Basel). 2022 Nov 22;14(23):5725. doi: 10.3390/cancers14235725.
3
Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART).
术前立体定向磁共振图像引导自适应放射治疗（A-SMART）后胰腺腺癌（PA）的手术及病理结果
Adv Radiat Oncol. 2022 Aug 6;7(6):101045. doi: 10.1016/j.adro.2022.101045. eCollection 2022 Nov-Dec.
4
Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer.不可切除胰腺癌的放疗和化疗的当代应用及疗效
Clin Transl Radiat Oncol. 2022 Apr 19;35:9-16. doi: 10.1016/j.ctro.2022.04.007. eCollection 2022 Jul.
5
Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm?局部晚期胰腺癌（LAPC）的消融放疗（ART）：迈向新范式？
Life (Basel). 2022 Mar 22;12(4):465. doi: 10.3390/life12040465.
6
The Therapeutic Potential of FLASH-RT for Pancreatic Cancer.FLASH放疗对胰腺癌的治疗潜力
Cancers (Basel). 2022 Feb 24;14(5):1167. doi: 10.3390/cancers14051167.
7
HIF2 Regulates Intestinal Wnt5a Expression.缺氧诱导因子2调节肠道Wnt5a表达。
Front Oncol. 2021 Nov 25;11:769385. doi: 10.3389/fonc.2021.769385. eCollection 2021.
8
Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma.新辅助放射治疗在胰腺腺癌治疗中的价值
J Clin Oncol. 2021 Dec 1;39(34):3773-3777. doi: 10.1200/JCO.21.01220. Epub 2021 Oct 8.